Registration number:
M&P Pharma Services Ltd
for the Year Ended 31 July 2024
M&P Pharma Services Ltd
Contents
Company Information |
|
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
M&P Pharma Services Ltd
Company Information
Directors |
M Bridgewater P W J Bridgewater |
Registered office |
|
Accountants |
|
M&P Pharma Services Ltd
(Registration number: 14220514)
Balance Sheet as at 31 July 2024
Note |
2024 |
(As restated) |
|
Fixed assets |
|||
Other financial assets |
1,495,454 |
- |
|
Current assets |
|||
Debtors |
- |
|
|
Cash at bank and in hand |
|
- |
|
|
|
||
Creditors: Amounts falling due within one year |
( |
- |
|
Net current assets |
|
|
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
- |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
400 |
100 |
|
Retained earnings |
(376) |
- |
|
Shareholders' funds |
24 |
100 |
For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
M&P Pharma Services Ltd
(Registration number: 14220514)
Balance Sheet as at 31 July 2024
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
|
M&P Pharma Services Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
General information |
The company is a private company limited by share capital, incorporated in England & Wales.
The address of its registered office is:
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
The financial statements have been prepared on a going concern basis.
Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
M&P Pharma Services Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
Other financial assets (current and non-current) |
Financial assets at fair value through profit and loss |
Total |
|
Non-current financial assets |
||
Cost or valuation |
||
Fair value adjustments |
9,975 |
9,975 |
Additions |
1,485,479 |
1,485,479 |
At 31 July 2024 |
1,495,454 |
1,495,454 |
Carrying amount |
||
At 31 July 2024 |
|
1,495,454 |
At 31 July 2024 the cost of the financial asset investments was £1,485,479.
Debtors |
Current |
2024 |
(As restated) |
Other debtors |
- |
|
- |
|
M&P Pharma Services Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
Creditors |
Creditors: amounts falling due within one year
2024 |
2023 |
|
Due within one year |
||
Accruals and deferred income |
|
- |
Creditors: amounts falling due after more than one year
Note |
2024 |
2023 |
|
Due after one year |
|||
Loans and borrowings |
|
- |
Share capital |
Allotted, called up and fully paid shares
2024 |
2023 |
|||
No. |
£ |
No. |
£ |
|
|
|
50 |
|
50 |
|
|
50 |
|
50 |
|
|
100 |
- |
- |
|
|
100 |
- |
- |
|
|
100 |
- |
- |
|
|
|
|
Loans and borrowings |
Non-current loans and borrowings
2024 |
2023 |
|
Other borrowings |
|
- |
Related party transactions |
Other transactions with directors |
At 31 July 2024 the company owed a balance of £1,601,169, which is included in Other borrowings due after more than one year.